Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-25 @ 4:49 PM
Study NCT ID:
NCT03760003
Status:
COMPLETED
Last Update Posted:
2025-11-28
First Post:
2018-11-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Sponsor:
Abivax S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-16
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-29
First Submit QC Date:
None
Study First Post Date:
2018-11-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-17
Results First Submit QC Date:
None
Results First Post Date:
2025-11-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED